JP2025506705A5 - - Google Patents
Info
- Publication number
- JP2025506705A5 JP2025506705A5 JP2024548610A JP2024548610A JP2025506705A5 JP 2025506705 A5 JP2025506705 A5 JP 2025506705A5 JP 2024548610 A JP2024548610 A JP 2024548610A JP 2024548610 A JP2024548610 A JP 2024548610A JP 2025506705 A5 JP2025506705 A5 JP 2025506705A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- solvate
- acceptable salt
- alkyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263311621P | 2022-02-18 | 2022-02-18 | |
| US63/311,621 | 2022-02-18 | ||
| PCT/US2023/013314 WO2023158802A1 (en) | 2022-02-18 | 2023-02-17 | Compounds and radioligands for targeting neurotensin receptor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506705A JP2025506705A (ja) | 2025-03-13 |
| JP2025506705A5 true JP2025506705A5 (https=) | 2026-02-25 |
Family
ID=87579080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548610A Pending JP2025506705A (ja) | 2022-02-18 | 2023-02-17 | ニューロテンシン受容体を標的とする化合物および放射性リガンドおよびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12145926B2 (https=) |
| EP (1) | EP4479040A1 (https=) |
| JP (1) | JP2025506705A (https=) |
| KR (1) | KR20240150464A (https=) |
| CN (1) | CN119136796A (https=) |
| AU (1) | AU2023221977A1 (https=) |
| CA (1) | CA3243418A1 (https=) |
| CL (1) | CL2024002422A1 (https=) |
| IL (1) | IL314786A (https=) |
| MX (1) | MX2024009858A (https=) |
| WO (1) | WO2023158802A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4479040A1 (en) | 2022-02-18 | 2024-12-25 | Full-Life Technologies HK Limited | Compounds and radioligands for targeting neurotensin receptor and uses thereof |
| WO2025146126A1 (en) * | 2024-01-04 | 2025-07-10 | Full-Life Technologies Hk Limited | Preparation method of compounds targeting neurotensin receptor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021556A (en) | 1987-07-22 | 1991-06-04 | Neorx Corporation | Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides |
| US5075099A (en) | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
| US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
| US5367080A (en) | 1990-11-08 | 1994-11-22 | Sterling Winthrop Inc. | Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
| DE4307983A1 (de) | 1993-03-13 | 1994-09-15 | Beiersdorf Ag | Wirkstoffe und kosmetische und dermatologische Zubereitungen |
| FR2732967B1 (fr) * | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
| US5886142A (en) | 1997-05-20 | 1999-03-23 | Thomas Jefferson University | Radiolabeled thrombus imaging agents |
| EP2740726A1 (en) * | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
| RU2743781C2 (ru) | 2014-06-10 | 2021-02-25 | 3Б Фармасьютикалз Гмбх | Конъюгат, содержащий лиганд рецепторов нейротензина, и его применение |
| EP3279197A1 (en) | 2016-08-03 | 2018-02-07 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Diagnosis, treatment and prevention of neurotensin receptor-related conditions |
| EP4479040A1 (en) | 2022-02-18 | 2024-12-25 | Full-Life Technologies HK Limited | Compounds and radioligands for targeting neurotensin receptor and uses thereof |
-
2023
- 2023-02-17 EP EP23756915.7A patent/EP4479040A1/en active Pending
- 2023-02-17 IL IL314786A patent/IL314786A/en unknown
- 2023-02-17 AU AU2023221977A patent/AU2023221977A1/en active Pending
- 2023-02-17 WO PCT/US2023/013314 patent/WO2023158802A1/en not_active Ceased
- 2023-02-17 JP JP2024548610A patent/JP2025506705A/ja active Pending
- 2023-02-17 KR KR1020247030010A patent/KR20240150464A/ko active Pending
- 2023-02-17 CA CA3243418A patent/CA3243418A1/en active Pending
- 2023-02-17 CN CN202380034728.3A patent/CN119136796A/zh active Pending
-
2024
- 2024-03-13 US US18/604,397 patent/US12145926B2/en active Active
- 2024-08-12 MX MX2024009858A patent/MX2024009858A/es unknown
- 2024-08-13 CL CL2024002422A patent/CL2024002422A1/es unknown
- 2024-09-25 US US18/895,915 patent/US20250026739A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650938B2 (ja) | 鉛またはトリウム放射性核種に連結されたｐｓｍａ標的化化合物を含む錯体 | |
| JP2728437B2 (ja) | 官能基化されたポリアミンキレート剤及びそのロジウム錯体並びにその製造法 | |
| JP2831073B2 (ja) | 大環状二官能キレート剤、その錯体及びそれらの抗体接合体 | |
| Gansow | Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates | |
| Price et al. | H4octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy | |
| JP6821558B2 (ja) | 腫瘍細胞を標的にするための代謝産物およびｅｐｒ剤の放射性医薬品コンジュゲート | |
| JP2024542592A5 (https=) | ||
| BR112021005931A2 (pt) | composto, complexo e composição farmacêutica | |
| CN108290924B (zh) | 肽硫脲衍生物、含有其的放射性同位素标记化合物、和含有该化合物作为活性成分的用于治疗或诊断前列腺癌的药物组合物 | |
| JP2025506705A5 (https=) | ||
| Scott Wilbur | Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides | |
| KR100330794B1 (ko) | 혈관질병진단제 | |
| JP7771080B2 (ja) | 医薬配合物 | |
| WO2026037323A1 (zh) | 放射性核素标记的靶向pd-l1小蛋白及其制备方法与应用 | |
| AU2003270347A1 (en) | Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same | |
| JP2009518373A (ja) | 線維症用の新規造影剤 | |
| JP4878119B2 (ja) | エナンチオマー純粋な（４Ｓ，８Ｓ）−及び（４Ｒ，８Ｒ）−４−ｐ−ニトロベンジル−８−メチル−３，６，９−トリアザ−３Ｎ，６Ｎ，９Ｎ−トリカルボキシメチル−１，１１−ウンデカン二酸及びそれらの誘導体、それらの製造方法並びに医薬品の製造のためのそれらの使用 | |
| JP2024115570A (ja) | 放射性核種標識薬剤 | |
| RU2024127322A (ru) | Соединения и радиолиганды для нацеливания на рецептор нейротензина и их применение | |
| Salih | Development of Chelators for Enhancing Radiometal-based Radiopharmaceuticals | |
| WO1994026315A1 (en) | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals | |
| WO1993012112A1 (en) | Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals | |
| Jowanaridhi | Development of Zirconium-89 Chelators for Use in Positron Emission Tomography Imaging | |
| KR100367264B1 (ko) | 거대환상킬레이트화제의제조방법및킬레이트의형성방법,및그방법에의해제조된결합체 | |
| JP5162081B2 (ja) | エナンチオマー純粋な（４Ｓ，８Ｓ）−及び（４Ｒ，８Ｒ）−４−ｐ−ベンジル−８−メチル−３，６，９−トリアザ−３Ｎ，６Ｎ，９Ｎ−トリカルボキシメチル−１，１１−ウンデカン二酸と生体分子との結合体、その塩の製造方法並びに医薬品の製造のためのそれらの使用 |